Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Genmab US, Inc.

The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with Blood Cancer United Podcast.

Join us for a powerful message of hope and perseverance after a cancer diagnosis. In this episode, Rashad Hayes shares his experience of being diagnosed with follicular lymphoma at 22 years old and how it motivated him to reevaluate his mindset and push forward. Now a social worker and motivational speaker, Rashad introduces his C.A.K.E. methodology, a unique approach to embracing life’s challenges.

Don’t miss out on this uplifting episode of resilience and adaptation in the face of cancer.

Mentioned on this episode: 

Additional LLS Support Resources: 

The post Don’t Burn Your CAKE: Embracing Life’s Challenges first appeared on The Bloodline with Blood Cancer United Podcast.

Navigating the maze of cancer care can be overwhelming.

Join us as Sara Grisales Jaramillo, LMSW, of CancerCare® discusses the challenges patients face in accessing affordable treatment and strategies to improve cancer outcomes.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, a member of the Roche Group.

The post Overcoming Barriers: Navigating Cancer Care first appeared on The Bloodline with Blood Cancer United Podcast.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®.

A diagnosis of cancer can present many challenges when it comes to relationships with others and the relationship you have with yourself. In this episode, we speak with experts about rediscovering yourself after cancer, exploring mental health treatment, and cancer “ghosting”.

Be sure to tune into our prior LIVE! At CancerCon episode, where we interviewed young adult patients and survivors to hear their thoughts on transitioning from their oncologist to a primary care provider.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, a member of the Roche Group.

The post LIVE! At CancerCon: Ghosts, Growth and Guidance first appeared on The Bloodline with Blood Cancer United Podcast.

There are new Medicare changes starting in January 2025 that will benefit cancer patients.   LLS Vice President of Federal Affairs, Brian Connell, joins us again on The Bloodline to inform us about these new changes and how they will impact Medicare patients.      

In this episode, you will learn about the key changes for Part D, the prescription drug plan for Medicare, as well as the drug plan for Medicare Advantage. One of these new changes requires action on the part of the Medicare enrollee, so be sure to tune in to learn more about how you can benefit.  

Mentioned on this episode: 

Additional LLS Support Resources: 

The post Medicare Updates: What You Need to Know for 2025 first appeared on The Bloodline with Blood Cancer United Podcast.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®.

Following a cancer diagnosis and treatment, oncologists often become the default primary care for patients. Transitioning away from the oncologist to a primary care provider for general healthcare may be challenging at times for patients but may have tremendous benefits. In this episode, we ask young adults with cancer about their experiences transitioning to primary care during or after treatment.

Be sure to stay tuned for the next episode from CancerCon, where we will be hearing from experts who presented on cancer “ghosting”, rediscovering yourself after cancer and mental health.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, a member of the Roche Group.

The post LIVE! At CancerCon: Transitioning to Primary Care first appeared on The Bloodline with Blood Cancer United Podcast.

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.  

However, there is a beacon of hope. Tune in to our latest episode, where we speak to Dr. Mayur Narkhede of the University of Alabama about groundbreaking research and innovative treatments for CLL. Discover the potential of CAR T-cell therapy, bispecific antibodies and other cutting-edge options that bring the promise of new hope and possibilities for those affected by CLL. Don’t miss this inspiring and informative discussion! 

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

The post Hope on the Horizon: Chronic Lymphocytic Leukemia first appeared on The Bloodline with Blood Cancer United Podcast.

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope!

Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the quality of life for CMML patients and bring us closer to a cure.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Taiho Oncology, Inc.

The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with Blood Cancer United Podcast.

The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell therapy and bispecific antibodies, researchers are making strides toward curative treatments and enhancing patients’ quality of life.

In this episode, we speak with Dr. David Bond from The Ohio State University about the latest developments in treating both aggressive and slow-growing non-Hodgkin lymphomas. He discusses innovative, newly approved therapies for patients, as well as how improvements in supportive care better manage the physical and emotional side effects of treatment.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

The post Innovative Therapies: Transforming Non-Hodgkin Lymphoma Care first appeared on The Bloodline with Blood Cancer United Podcast.

Exercise, or simply moving the body, can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park Comprehensive Cancer Center and blood cancer survivors, Paul Rothweiler and Joe Grey, share about a clinical trial they developed to introduce a personalized strength training program to patients and caregivers.

Dr. Holtan highlights the benefits of strength training for all patients, while Paul and Joe share how exercise has aided their physical and emotional recovery during and after their treatments. For patients and survivors who may be fearful or nervous about starting an exercise program, this episode is for you!

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, a member of the Roche Group.

The post Exercise and Cancer: Celebration That You CAN first appeared on The Bloodline with Blood Cancer United Podcast.